WinstonWınston
Back
Drug Free Solution logo

Drug Free Solution

DSOL
Medical - Healthcare Information Services · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$113,361
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+15.9% over 6y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 244.6M (2019) → 283.4M (2025)

Winston Score History

The full picture

Drug Free Solution, Inc. is a small healthcare company focused on substance abuse treatment and recovery services. It works to help people struggling with drug and alcohol addiction by connecting them with treatment programs and support resources. The company operates in the behavioral health space, which is a growing part of the broader healthcare industry.

The company appears to generate revenue through service fees related to addiction treatment referrals or program management, though its financial profile shows minimal reported revenue and zero gross margin, suggesting it is in an early or developmental stage. It operates primarily in the United States and has a very small market presence with a market cap that rounds to zero. The main risk facing the business is its lack of demonstrated revenue and profitability, which raises serious questions about its ability to fund operations and scale over time.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

R&D Spend

$0/ year

Research and development spending

Insider Activity

59.7%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~0 months

$7 cash & investments

Quarterly Free Cash Flow

Short runway — potential dilution ahead through share issuance

Cash watch

Drug Free Solution has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
3/4 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial